Bonk (NASDAQ:BNKK) Director Buys $16,440.00 in Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy bought 12,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was bought at an average cost of $1.37 per share, for a total transaction of $16,440.00. Following the completion of the acquisition, the director owned 63,341 shares in the company, valued at $86,777.17. This trade represents a 23.37% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Mitchell Austin Rudy also recently made the following trade(s):

• On Thursday, April 9th, Mitchell Austin Rudy purchased 31,055 shares of Bonk stock. The stock was acquired at an average price of $2.82 per share, with a total value of $87,575.10.

Bonk Trading Down 2.2%

BNKK stock traded down $0.03 during trading on Tuesday, reaching $1.33. The company’s stock had a trading volume of 125,977 shares, compared to its average volume of 417,288. Bonk, Inc. has a 1 year low of $1.25 and a 1 year high of $46.90. The company’s fifty day moving average is $2.21 and its 200-day moving average is $3.18.

Bonk (NASDAQ:BNKK) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. The business had revenue of $0.79 million during the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on BNKK shares. Weiss Ratings downgraded shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. Wall Street Zen raised shares of Bonk from a “sell” rating to a “hold” rating in a research note on Saturday. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Institutional Trading of Bonk

Several institutional investors and hedge funds have recently modified their holdings of the stock. Geode Capital Management LLC acquired a new position in Bonk during the fourth quarter valued at $128,000. Jane Street Group LLC acquired a new position in shares of Bonk in the fourth quarter worth about $96,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Bonk in the fourth quarter worth about $37,000. Finally, State Street Corp acquired a new position in shares of Bonk during the 4th quarter worth about $33,000. Institutional investors own 12.55% of the company’s stock.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.